Embed Size (px)
DESCRIPTION
NHS Cervical Screening Programme, England 2009-10: Graphs. Figure 1: Cervical screening: Coverage of the target age group (25-64), England at 31 March, 2000 to 2010. Source: KC53, The NHS Information Centre. Figure 2: Cervical screening: Coverage by age, England, 2008-09 and 2009-10. - PowerPoint PPT Presentation
Citation preview
NHS Cervical Screening Programme, England 2009-10: Graphs
Figure 1: Cervical screening: Coverage of the target age group (25-64), England at 31 March, 2000 to 2010
65
70
75
80
85
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
2006 data as at 10th August 2006
© Data prior to 2005, re-used w ith the permission of the Department of Health
% coverage (less than 5 years since last adequate test)
Source: KC53, The NHS Information Centre.
Figure 2: Cervical screening: Coverage by age, England, 2008-09 and 2009-10
Source: KC53, The NHS Information Centre
Source: KC53, The NHS Information Centre
Figure 3 - Cervical screening: coverage of the target age group (25-64) by Primary Care Organisation, England 31 March 2010
Figure 3a - Cervical screening: coverage of the target age group (25-64) by Primary Care Organisation, England 31 March 2010
Source: KC53, The NHS Information Centre.
Figure 4: Number of women invited for screening by age group and year, 2005-06 to 2009-10
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
2005-06 2006-07 2007-08 2008-09 2009-10
Year
Nu
mb
er 25-49
50-64
25-64
Source: KC53, The NHS Information Centre.
Figure 5: Number of women tested by year and age group , 2005-06 to 2009-10
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
2005-06 2006-07 2007-08 2008-09 2009-10
Year
Nu
mb
er 25-49
50-64
25-64
Source: KC53, The NHS Information Centre.
Figure 6* - Cervical screening: women with test result severe dyskaryosis or worse as a percentage of all women with adequate test results, by age, England 2009-10.
1.63
1.12
0.75
0.49
0.320.27 0.29
0.24
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
Percentage
Age
* This chart is shown to 2 decimal places due to the very small percentages involved.
Source: KC53 Part C, The NHS Information Centre.
Figure 7 - Cervical screening: Percentage of tests for women aged 25-64, with an abnormal result by Primary Care Organisation, England 2009-10
7
24
32
41
25
14
4 3 2
0
5
10
15
20
25
30
35
40
45
0 1 2 3 4 5 6 7 8 9 10 11 12 13
Number of PCOs
Percentage of abnormal samples
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 14
Source: KC53 Part C, The NHS Information Centre.
Figure 8: Cervical Screening: Proportion of results available within 4 weeks by Strategic Health Authority, 2009-10
44.6 48.5
33.4
64.1
50.3
31.7
47.2 48.5
31.136.7
55.3
27.127.3
31.5
26.8
24.6
20.5
23.3 23.8
37.635.3
25.6
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
England North East NorthWest
Yorkshire& the
Humber
EastMidlands
WestMidlands
East ofEngland
London South EastCoast
SouthCentral
SouthWest
%
>2 to 4 weeks
Up to 2 weeks
71.8 72.068.7
72.370.5
52.3
75.0
90.9
64.9
75.880.9
Source: KC53 Part C, The NHS Information Centre.
Figure 9 - Cervical cytology: Percentages of samples from GP & NHS Community Clinics found to be inadequate, from women of all ages, England 2000 to 2010
0
2
4
6
8
10
12
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
© Data prior to 2005, re-used with the permission to the Department of Health
Percentage
Source: KC53 Part C, The NHS Information Centre.
Figure 10 - Cervical cytology: Percentage of samples from GP & NHS Community Clinics found to be inadequate, for women aged 25-64, by laboratory, England 2009-10
Source: KC53 Part C, The NHS Information Centre.
Figure 11 - Outcome of referral, following persistent non-negative test result, England April 2009 - June 2009
Cervical Cancer, 0.1
CIN3 or Adenocarcinoma in
situ, 7.2
CIN2, 10.2
CIN1, 25.6
Non Cervical Cancer, 0.1
Other, 56.8
Source: KC53 Part C, The NHS Information Centre.
Figure 12 - Outcome of referral, following single occurrence of potentially significant abnormality, England April 2009 - June 2009
CIN3 or Adenocarcinoma in situ, 57.4
CIN2, 22.7
CIN1, 8.4
Other, 8.5
Non Cervical Cancer, 0.3
Cervical Cancer, 2.7
Source: KC53 Part C, The NHS Information Centre.
Figure 13 - Positive Predictive Value, England April 2009 - June 2009
47
15
40
28
18
10
5
10
15
20
25
30
35
40
55 60 65 70 75 80 85 90 95
Number of Laboratories
Positive Predictive Value (%)
55 60 65 70 75 80 85 90 95 100
Source: KC53 Part C, The NHS Information Centre.
Figure 14 - Women referred to colposcopy: time from referral to first offered appointment by indication, 2009-10
Source: KC53 Part C, The NHS Information Centre.
0%
20%
40%
60%
80%
100%
All Referrals Inadequate Borderline /Mild
Dyskaryosis
Moderate /Severe
Dyskaryosis
Severe /?Invasive /Glandularneoplasia
ClinicalIndication
Other
Referral result
Percentage
Over 12 w eeks
>8 to 12 w eeks
>4 to 8 w eeks
>2 to 4 w eeks
<=2 w eeks
Figure 15 - Biopsies taken at colposcopy: time from biopsy until patient informed of result (4 month sample) - 2009-10
30.5
45.0
20.1
2.4 2.0
0.0
20.0
40.0
60.0
<=2wks >2 - 4 wks >4 - 8 wks >8 - 12 wks >12 wks
Percentage
Source: KC53 Part C, The NHS Information Centre.
